Dow Jones

40,211.72

0.53%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

CGEN

Compugen (CGEN)

Compugen Ltd

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CGEN

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
11/11/2016	10:45	PR Newswire (US)	Compugen Immune Checkpoint Program Demonstrates Potential for Development of New Cancer Immunotherapy Treatments	NASDAQ:CGEN	Compugen Ltd
07/11/2016	06:11	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
07/11/2016	06:07	PR Newswire (US)	Compugen Ltd. Reports 3rd Quarter 2016 Financial Results	NASDAQ:CGEN	Compugen Ltd
03/11/2016	08:53	PR Newswire (US)	Compugen to Host R&D Day on December 7, 2016 in New York	NASDAQ:CGEN	Compugen Ltd
14/10/2016	15:03	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NASDAQ:CGEN	Compugen Ltd
12/10/2016	05:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CGEN	Compugen Ltd
10/10/2016	06:00	PR Newswire (US)	Compugen Third Quarter Financial Statements to be Released November 7, 2016	NASDAQ:CGEN	Compugen Ltd
07/10/2016	06:00	PR Newswire (US)	Compugen to Present at the Annual Meeting of the Society for Immunotherapy of Cancer Next Month	NASDAQ:CGEN	Compugen Ltd
30/08/2016	06:00	PR Newswire (US)	Compugen Discloses Development of Enhanced LINKS Platform Utilized for the Discovery of Myeloid Targets for Cancer Immunother...	NASDAQ:CGEN	Compugen Ltd
25/08/2016	09:13	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:CGEN	Compugen Ltd
09/08/2016	05:32	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:CGEN	Compugen Ltd
02/08/2016	06:01	PR Newswire (US)	Compugen Ltd. Reports 2nd Quarter 2016 Financial Results	NASDAQ:CGEN	Compugen Ltd
21/07/2016	06:00	PR Newswire (US)	Compugen Second Quarter 2016 Conference Call Scheduled for Tuesday, August 2, 2016 at 10:00 AM ET	NASDAQ:CGEN	Compugen Ltd
22/06/2016	06:09	PR Newswire (US)	Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program	NASDAQ:CGEN	Compugen Ltd
15/06/2016	06:00	PR Newswire (US)	Compugen to Present at JMP Securities Life Sciences Conference in New York	NASDAQ:CGEN	Compugen Ltd
23/05/2016	06:00	PR Newswire (US)	Compugen to Present at the Jefferies Global Healthcare Conference in New York	NASDAQ:CGEN	Compugen Ltd
16/05/2016	06:00	PR Newswire (US)	Compugen to Present at the Oppenheimer Annual Israeli Conference in Tel Aviv	NASDAQ:CGEN	Compugen Ltd
10/05/2016	06:01	PR Newswire (US)	Compugen Ltd. Reports First Quarter 2016 Financial Results	NASDAQ:CGEN	Compugen Ltd
10/05/2016	05:45	PR Newswire (US)	Steven Holtzman Joins Compugen as Strategic Business Advisor	NASDAQ:CGEN	Compugen Ltd
27/04/2016	06:15	PR Newswire (US)	Compugen First Quarter 2016 Conference Call and Webcast Scheduled for Tuesday, May 10, 2016 at 10:00 AM ET	NASDAQ:CGEN	Compugen Ltd
18/04/2016	06:14	PR Newswire (US)	Compugen Achieves Preclinical Milestone in Cancer Immunotherapy Collaboration With Bayer	NASDAQ:CGEN	Compugen Ltd
06/04/2016	06:00	PR Newswire (US)	Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director at Compugen USA, Inc.	NASDAQ:CGEN	Compugen Ltd
28/03/2016	06:00	PR Newswire (US)	Compugen to Present at the Jefferies Immuno-Oncology Summit in Boston	NASDAQ:CGEN	Compugen Ltd
29/02/2016	06:00	PR Newswire (US)	Compugen Presents Results for CGEN-15029 Immuno-Oncology Therapeutic Program	NASDAQ:CGEN	Compugen Ltd
09/02/2016	06:09	PR Newswire (US)	Compugen Ltd. Reports Fourth Quarter and Calendar 2015 Results	NASDAQ:CGEN	Compugen Ltd
26/01/2016	06:00	PR Newswire (US)	Compugen Fourth Quarter and Yearend 2015 Conference Call Scheduled for Tuesday, February 9, 2016 at 10:00 AM EST	NASDAQ:CGEN	Compugen Ltd
11/12/2015	08:06	Business Wire	Compugen Achieves Third Preclinical Milestone in Cancer Immunotherapy Collaboration with Bayer	NASDAQ:CGEN	Compugen Ltd
24/11/2015	06:00	Business Wire	Compugen to Present at the Oppenheimer Healthcare Conference in New York	NASDAQ:CGEN	Compugen Ltd
12/11/2015	06:00	Business Wire	Compugen to Present at Jefferies 2015 Global Healthcare Conference in London	NASDAQ:CGEN	Compugen Ltd
09/11/2015	06:00	Business Wire	Compugen Presents Translational Study Results Supporting CGEN-15001 for the Treatment of Rheumatoid Arthritis	NASDAQ:CGEN	Compugen Ltd